CureAA: Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia

Sponsor

Contact Info

Amy DeZern, MD, MHS

Adezern1@jhmi.edu

(410) 502-7208

Start Date: December 1, 2024 End Date: February 1, 2029

ClinicalTrials.gov Identifier: NCT06517641

Clinical Trial: A type of research study that tests how a drug, medical device, or treatment approach works in people. There are several types of clinical trials. Treatment trials test new treatment options. Diagnostic trials test new ways to diagnose a disease. Screening trials test the best way to detect a disease or health problem. Quality of life (supportive care) trials study ways to improve the comfort of people with chronic illness. Prevention trials look for better ways to prevent disease in people who have never had the disease. Trials are in four phases. Phase I tests a new drug or treatment in a small group to see if it is safe. Phase II expands the study to a larger group of people to find out if it works. Phase III expands the study to an even larger group of people to compare it to the standard treatment for the disease; and Phase IV takes place after the drug or treatment has been licensed and marketed to find out the long-term impact of the new treatment. If you are interested in learning more about your possible participation in this clinical trial, please complete the form. Your information will be forwarded directly to the trial sponsor.

Purpose

This is a Phase II study of hematopoietic stem cell transplantation for previously untreated patients with severe aplastic anemia: (ay-PLASS-tik uh-NEE_mee-uh) A rare and serious condition in which the bone marrow fails to make enough blood cells - red blood cells, white blood cells, and platelets. The term aplastic is a Greek word meaning not to form. Anemia is a condition that happens when red blood cell count is low. Most… . This study is comprised of two cohorts - patients receiving haploidentical donor transplant and patients receiving unrelated donor: A donor that is not a sibling or other familial relation of the patient (recipient). transplant. The goal is to enroll 60 participants total, 30 in each cohort.

Status
Recruiting
Bone Marrow Disease(s)
Aplastic Anemia
Associated Drug(s)
Antithymocyte Globulin
Cyclosporine
Fludarabine
Phase
Phase 2
Gender
Female
Male
Age Group
3 years to 75 years
Accepts Healthy Volunteers
No
Inclusion Criteria

Patients with a diagnosis of Severe Aplastic Anemia: (ay-PLASS-tik uh-NEE_mee-uh) A rare and serious condition in which the bone marrow fails to make enough blood cells - red blood cells, white blood cells, and platelets. The term aplastic is a Greek word meaning not to form. Anemia is a condition that happens when red blood cell count is low. Most… who do not have a fully HLA: See human leukocyte antigen. -matched related sibling donor who have not received any prior treatment. Patients need to have adequate organ function to be able to tolerate a reduced-intensity hematopoietic cell transplant.

Exclusion Criteria

Patients with Inherited or Congenital Bone Marrow Failure: A condition that occurs when the bone marrow stops making enough healthy blood cells. The most common of these rare diseases are aplastic anemia, myelodysplastic syndromes (MDS) and paroxysmal nocturnal hemoglobinuria (PNH). Bone marrow failure can be acquired (begin any time in life) or can be… Syndromes are not eligible for this study. Patients cannot have received previous treatment for Aplastic Anemia: (ay-PLASS-tik uh-NEE_mee-uh) A rare and serious condition in which the bone marrow fails to make enough blood cells - red blood cells, white blood cells, and platelets. The term aplastic is a Greek word meaning not to form. Anemia is a condition that happens when red blood cell count is low. Most… and cannot have inadequate organ function, uncontrolled infection, or have received a prior solid organ transplant. Patients who are pregnant are not eligible for hematopoietic cell transplantation.

Find Out More:

Disclaimer:

AAMDSIF does not recommend, endorse, or make any representation about the efficacy, appropriateness or suitability of any clinical trial listed on this website. Pharmaceutical company sponsored content is highlighted only to give additional information about the trial. All trials are listed on https://clinicaltrials.gov/. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a clinical trial, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.